A Study to Measure the Expression of the HER2‐HER3 Dimer in Tumor and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies. The gene discussed is ERBB2; the disease is neoplasm.